[1. Arslan S., Ugurlu S, Bulut G. Akkurt I. The association between plasma D-dimmer levels and community-acquired pneumonia. Clinics 2010; 65(6): 593–7.10.1590/S1807-59322010000600006289855020613935]Search in Google Scholar
[2. Milbrandt EB, Reade MC, Lee M, et al. Prevalence and Significance of Coagulation Abnormalities in Community-Acquired Pneumonia. Molec Med 2009; 15(11–12): 438–445.10.2119/molmed.2009.00091274320519753144]Search in Google Scholar
[3. Querol-Ribelles JM, Tenias JM, Grau E, et al. Plasma D-dimer levels correlate with outcomes in patients with community-acquired pneumonia Chest, 2004; 126(4): 1087–1092.]Search in Google Scholar
[4. Freyburger G, Trillaund H, Labrouche S, Gauther P, Javorschi S, Bernard P, et al D dimmer strategy in thrombosis exclusion- a gold standard study in 100 patients suspected of deep venous thrombosis or pulmonary embolism: 8 DD metods compared. Thromb Haemost 1998; 79: 32–7.10.1055/s-0037-1614214]Search in Google Scholar
[5. Levi M, Keller TT, Van Gorp E, Ten Cate H. Infection and inflammation and the coagulation system Cardiovasc. Res. 60(2003) 26–39.]Search in Google Scholar
[6. Yende S, D’Angelo G, Mayr F, et al. Elevated Hemostasis Markers after Pneumonia Increases One-Year Risk of All-Cause and Cardiovascular Deaths. Bozza PT, ed. PLoS ONE. 2011; 6(8): e22847.10.1371/journal.pone.0022847315426021853050]Search in Google Scholar
[7. Light RW Parapneumonic effusions and empyema Proc Am Thorac Soc. 2006; 3(1): 75–80.10.1513/pats.200510-113JH16493154]Search in Google Scholar
[8. Chapman SJ, Davies RJO The management of pleural space infection. Respitology 2004; 9: 4–11.]Search in Google Scholar
[9. Light RW. Pleural diseases, 4th ed Baltimore: Lippincott, Williams and Wilkins; 2001.]Search in Google Scholar
[10. Medford AR, Maskell N. Pleural effusion. Postgrad Med J 2005; 81: 702e10.10.1136/pgmj.2005.035352174339716272233]Search in Google Scholar
[11. Costa Vaz MA, Vargas FS, Marinho FCA, D’Amico EA, Rocha TRF, Teixeira LR. Does the evaluation of coagulation factors contribute to etiological diagnosis of pleural effusions?. Clinics. 2009; 64(9): 891–5.10.1590/S1807-59322009000900010]Search in Google Scholar
[12. Kabrhel C, Courtney DM, Camargo CA, et al. Factors associated with positive D-dimer results in patients evaluated for pulmonary embolism. Academic emergency medicine: 2010; 17(6): 589–597.10.1111/j.1553-2712.2010.00765.x353803120624138]Search in Google Scholar
[13. Nguyen HB, Loomba M, Yang JJ, et al. Early lactate clearance is associated with biomarkers of inflammation, coagulation, apoptosis, organ dysfunction and mortality in severe sepsis and septic shock. Journal of Inflammation. 2010; 7: 6.10.1186/1476-9255-7-6283700020181046]Search in Google Scholar
[14. Barthwal M.S. Intrapleural fibrinolytic therapy in complicated parapneumonic effusion and empyema: present status. Indian journal of chest diseases and allied sciences 50.3 (2008): 277.]Search in Google Scholar
[15. Satoshi G, Toshiaki I., Yutaka I, et al A multicenter, prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients: Comparing current criteria Critical Care Medicine: 2006; 34(3): 625–631.]Search in Google Scholar
[16. Kale S, Yende S, Kong L, et all The effects of age on inflammatory and coagulation-fibrinolysis response in patients hospitalized for pneumonia. PLoS One. 2010; 5(11): e 13852.10.1371/journal.pone.0013852297397621085465]Search in Google Scholar
[17. Lee MH, Nahm CH, Choi JW. Thrombin-antithrombin III complex, proinflammatory cytokines, and fibrinolytic indices for assessing the severity of inflamemation in pleural effusions. Ann Clin Lab Sci. 2010 Fall; 40(4): 342–7.]Search in Google Scholar
[18. Chalmers JD, Singanayagam A, Murray MP, et all. Risk factors for complicated parapneumonic effusion and empyema on presentation to hospital with community-acquired pneumonia. Thorax. 2009 Jul; 64(7): 592–7.10.1136/thx.2008.10508019131449]Search in Google Scholar
[19. El-Habashy M, Elmahalawy I.I, Sonobol A. Value of D-dimer and alkaline phosphatase in the diagnosis of pleural effusion Egyptian Journal of Chest diseases and tuberculosis 2014; 63: 869–872.]Search in Google Scholar
[20. Dikensoy O., Stathopoulos G.T., Zhu Z, Light R.W. D-dimmer levels in leural effusion Respiratory Medicine 2006; 100: 1337–1341.]Search in Google Scholar
[21. Seligman R, Ramos-Lima LF, do Amaral Oliveira V, Sanvicente C, Pacheco EF, Rosa KD. Biomarkers in community-acquired pneumonia: A state-of-the-art review. Clinics. 2012; 67(11): 1321–1325.10.6061/clinics/2012(11)17]Search in Google Scholar
[22. Christ-Crain M, Opal SM Clinical review: the role of biomarkers in the diagnosis and management of community-acquired pneumonia. Crit Care. 2010; 14(1): 203.10.1186/cc8155]Search in Google Scholar
[23. Rohacek M, Szucs-Farkas Z., Pfortmüller C.A. et all Acute Cardiac Disorder or Pneumonia and Concomitant Presence of Pulmonary Embolism. PLoS One. 2012; 7(10): e7418.10.1371/journal.pone.0047418]Search in Google Scholar
[24. Woodhouse PR, Khnaw K T, Plummer M, Foley A, Meade TW. Seasonal variations of plasma fibrinogen and factor VII activity in the elderly: winter infections and death from cardiovasucalre disease. Lancet; 1994:19; 343: 435–439.10.1016/S0140-6736(94)92689-1]Search in Google Scholar
[25. Serhan CN, Chiang N, Van Duke TE Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immnol 2008; 8: 349–361.10.1038/nri2294274459318437155]Search in Google Scholar
[26. Kasal J, Jovanovic Z, Clermont G, Weissfeld LA, Kaplan V, et al. Comparison of Cox and Gray’s survival models in severe sepsis. Crit Care Med; 2004: 32: 700–707.10.1097/01.CCM.0000114819.37569.4B]Search in Google Scholar